Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study

Published on 08.06.2021 in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29208, first published March 29, 2021.

Alison Edelman ^{1
*} , MD, MPH ;   Agnes Hemon ^{2
*} , MSc ;   Mitchell Creinin ^{3
*} , MD ;   Pascale Borensztein ^{2
*} , MD ;   Bruno Scherrer ^{4
*} , PhD ;   Anna Glasier ^{5
*} , MD

¹ Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, United States

² Laboratoire HRA Pharma, Chatillon, France

³ Department of Obstetrics & Gynecology, University of California, Davis Health, Sacramento, CA, United States

⁴ Bruno Scherrer Conseil, St Arnoult en Yvelines, France

⁵ Centre for Reproductive Health, University of Edinburgh, Edinburgh, United Kingdom

*all authors contributed equally

Corresponding Author: